Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Laurence Van Bree"'
Autor:
Stephane Ferretti, Sébastien Jeay, Ensar Halilovic, Claire Fabre, Laurence Van Bree, Christophe Meille, Jens Wuerthner, Florence Hourcade-Potelleret, Sebastian Bauer, Reinhard Dummer, Philippe A. Cassier, Astrid Jullion, George D. Demetri, Nelson Guerreiro, Daniel Shao-Weng Tan
Publikováno v:
British Journal of Cancer
Background CGM097 inhibits the p53-HDM2 interaction leading to downstream p53 activation. Preclinical in vivo studies support clinical exploration while providing preliminary evidence for dosing regimens. This first-in-human phase I study aimed at as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::962edae56c80ae45d9537101a31228f2
https://doi.org/10.1038/s41416-021-01444-4
https://doi.org/10.1038/s41416-021-01444-4
Autor:
Claire Cropet, Gregor Verhoef, Enrica Morra, Mats Björeman, Laurence Van Bree, Juan Luis Steegmann, Isidro Villanueva, Karin Cerri, David Marin Costa, Muriel Sterckx, Mauricette Michallet, Gert J. Ossenkoppele, Thomas Kühr
Publikováno v:
Blood. 110:1951-1951
Imatinib is widely used for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), and is associated with improved response rates in these patients. However, the management of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88a206395d6926353d6b82a1cd166b3f
https://doi.org/10.1182/blood.v110.11.1951.1951
https://doi.org/10.1182/blood.v110.11.1951.1951